269
Participants
Start Date
April 30, 2016
Primary Completion Date
March 31, 2017
Study Completion Date
April 30, 2017
PF-04965842
10 mg of PF-04965842 QD for 12 weeks
PF-04965842
30 mg of PF-04965842 QD for 12 weeks
PF-04965842
100 mg of PF-04965842 QD for 12 weeks
PF-04965842
200 mg of PF-04965842 QD for 12 weeks
Placebo
Placebo QD for 12 weeks
Australian Clinical Research Network, Sydney
Woden Dermatology, Phillip
Sinclair Dermatology, East Melbourne
Royal Melbourne Hospital, Parkville
CRU Hungary Ltd., MISEK-CRU, Miskolc
Veracity Clinical Research, Woolloongabba
The Skin Centre, Benowa
Allergo-Derm Bakos Kft., Szolnok
North Eastern Health Specialists, Hectorville, South Australia
Bacs Kiskun Megyei Korhaz, Bor es Nemibeteggondozo, Kecskemét
Fremantle Dermatology, Fremantle
Szegedi Tudomanyegyetem SzentGyorgyi Albert Klinikai Kozpont Borgyogyaszati es Allergologiai Klinika, Szeged
Sadick Research Group, New York
ISA GmbH, Berlin
Forest Hills Dermatology Group, Forest Hills
UPMC Department of Dermatology, Pittsburgh
DermDox Centers for Dermatology, Hazleton
West End Dermatology Associates, Richmond
Virginia Clinical Research,Inc, Norfolk
Universitaetsklinikum Schleswig-Holstein, Lübeck
MedaPhase, Inc., Newnan
Park Avenue Dermatology Administration Annex, Orange Park
Park Avenue Dermatology, Orange Park
Leavitt Medical Associates of Florida d/b/a Ameriderm Research, Ormond Beach
North Florida Dermatology Associates, PA, Jacksonville
Forward Clinical Trials, Inc., Tampa
Olympian Clinical Research, Clearwater
Clinical Research Center of Alabama, Birmingham
DS Research, Louisville
The Indiana Clinical Trials Center, Plainfield
Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Dawes Fretzin Dermatology Group, LLC, Indianapolis
Somerset Skin Centre, Troy
Universitaetsklinikum Muenster, Münster
Health Concepts, Rapid City
Dundee Dermatology, West Dundee
MediSearch Clinical Trials, Saint Joseph
Shondra L Smith, MD Dermatology & Advanced Aesthetics, Lake Charles
Universitaetsklinikum Tuebingen, Tübingen
Vital Prospects Clinical Research Institute, P.C, Tulsa
Bellaire Dermatology Associates, Bellaire
Texas Dermatology and Laser Specialists, San Antonio
Clinical Research Consortium, Las Vegas
Peninsula Research Associates, Inc., Rolling Hills Estates
Clinical Science Institute, Santa Monica
Huntington Medical Foundation, Pasadena
California Dermatology & Clinical Research Institute, Encinitas
TCR Medical Corporation, San Diego
Emil A. Tanghetti MD dba Center for Dermatology and Laser Surgery, Sacramento
University of Connecticut Health Center (UConn Health), Farmington
Psoriasis Treatment Center of Central New Jersey, East Windsor
The Dermatology Group, P.C, Verona
Clinical Partners, LLC, Johnston
University of British Columbia, Vancouver
Wiseman Dermatology Research Inc., Winnipeg
Lynderm Research Inc., Markham
Research by ICLS, Oakville
Skin Centre for Dermatology, Peterborough
The Centre for Dermatology, Richmond Hill
K. Papp Clinical Research, Waterloo
Windsor Clinical Research Inc, Windsor
Innovaderm Research Inc., Montreal
Centre de Recherche Dermatologique du Quebec metropolitain (CRDQ), Québec
Diex Research Sherbrooke Inc., Sherbrooke
Lead Sponsor
Pfizer
INDUSTRY